Retrospective evidence for a biological cost of vancomycin resistance determinants in the absence of glycopeptide selective pressures
about
The fitness costs of antibiotic resistance mutationsManagement options for reducing the release of antibiotics and antibiotic resistance genes to the environmentDetecting rare gene transfer events in bacterial populationsVancomycin resistant enterococci in farm animals - occurrence and importanceOn being the right size: the impact of population size and stochastic effects on the evolution of drug resistance in hospitals and the communityCycling empirical antibiotic therapy in hospitals: meta-analysis and models.Integrons: Vehicles and pathways for horizontal dissemination in bacteria.Proof of concept for eradication of vancomycin resistant Enterococcus faecium from broiler farms.Country-specific antibiotic use practices impact the human gut resistome.Multidrug-Resistant Bacteria in the Community: Trends and Lessons Learned.Twenty-five years of shared life with vancomycin-resistant enterococci: is it time to divorce?A proposed analytic framework for determining the impact of an antimicrobial resistance intervention.Positive selection and compensatory adaptation interact to stabilize non-transmissible plasmids.Assessing the probability of detection of horizontal gene transfer events in bacterial populations.Fitness costs of various mobile genetic elements in Enterococcus faecium and Enterococcus faecalis.Spread of multidrug-resistant Enterococcus to animals and humans: an underestimated role for the pig farm environment.Conserved collateral antibiotic susceptibility networks in diverse clinical strains of Escherichia coli
P2860
Q26825334-1F60D436-21B7-4ECF-A897-5C8E9C8401EFQ26827456-C915638D-2F00-408E-AD06-85F2840E7F7EQ27686958-55B0D1DE-03A4-4752-9F7E-F77463E99036Q28274515-425485EC-8CE3-461B-9C85-8D2DCF42CA61Q28477757-E86A6AA7-B74B-42F4-A086-534BB9ACEE26Q33812804-FF724217-AAC7-47F9-BC5D-2A5A2F6FC179Q36618578-754B3702-2043-40C3-A0CE-B11B9502934BQ36958502-94CF16A2-38E2-4F67-B315-7F4A66074ADFQ36973632-8794C643-E0F0-4C04-9B23-EE011232EC2EQ37648626-B94E9B29-8C13-454A-9A89-8972C8D2AF28Q38064807-B52DFFA7-654A-472F-9657-D44E0F68A880Q38785263-C09DC7C0-5F9E-484F-8E7F-D80C6FE102A2Q39427316-B17633E9-D348-4B97-BEF1-5B463B64F886Q39648377-99DE5F78-C4F2-48F3-A456-A709C570EAB5Q42918721-6F6B6AAD-3518-41DA-B47B-F9A44A7D46EBQ45364451-02505FE1-9683-4C1D-B0BF-E57F3F557D7FQ58756032-ECBC52DF-DACE-40E6-9D65-585CCFDC0068
P2860
Retrospective evidence for a biological cost of vancomycin resistance determinants in the absence of glycopeptide selective pressures
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Retrospective evidence for a b ...... ycopeptide selective pressures
@ast
Retrospective evidence for a b ...... ycopeptide selective pressures
@en
Retrospective evidence for a b ...... ycopeptide selective pressures
@nl
type
label
Retrospective evidence for a b ...... ycopeptide selective pressures
@ast
Retrospective evidence for a b ...... ycopeptide selective pressures
@en
Retrospective evidence for a b ...... ycopeptide selective pressures
@nl
prefLabel
Retrospective evidence for a b ...... ycopeptide selective pressures
@ast
Retrospective evidence for a b ...... ycopeptide selective pressures
@en
Retrospective evidence for a b ...... ycopeptide selective pressures
@nl
P2093
P2860
P356
P1476
Retrospective evidence for a b ...... ycopeptide selective pressures
@en
P2093
G S Simonsen
J P Townsend
K M Nielsen
P J Johnsen
P2860
P304
P356
10.1093/JAC/DKQ512
P407
P577
2011-01-07T00:00:00Z